The comparative effects of clozapine versus haloperidol on initiation and maintenance of alcohol drinking in male alcohol-preferring P rat.

The comparative effects of clozapine versus haloperidol on initiation and maintenance of alcohol drinking in male alcohol-preferring P rat.
复制标题

DOI:
10.1016/j.alcohol.2013.10.002
复制
发表时间:
2013-12
期刊:
Alcohol (Fayetteville, N.Y.)
影响因子:
--
通讯作者:
Green AI
Green AI
中科院分区:
其他
文献类型:
--
作者:
Chau DT;Khokhar JY;Dawson R;Ahmed J;Xie H;Green AI

文献摘要

参考文献

被引文献

相似文献

Alcohol use disorder, characterized by modest levels of alcohol use, commonly occurs in patients with schizophrenia and dramatically worsens their course. Recent data indicate that the atypical antipsychotic clozapine, but not the typical antipsychotic haloperidol, decreases alcohol drinking both in patients with schizophrenia and also in the Syrian golden hamster, an animal of moderate alcohol drinking. The present study was designed to assess the comparative effects of clozapine and haloperidol in the alcohol-preferring (P) rat, an animal model of alcoholism. First, the study investigated the comparative effects of clozapine and haloperidol on initiation of alcohol consumption in P rats, which models the early stage of alcoholism. Second, the study assessed the comparative effects of clozapine and haloperidol on maintenance of chronic alcohol consumption in P rats to provide a clue as to whether either drug may also limit alcohol consumption in alcohol-dependent patients. Clozapine attenuated the initiation of alcohol drinking and development of alcohol preference while haloperidol did not. However, neither clozapine nor haloperidol attenuated maintenance of chronic alcohol drinking. Taken together, the current data suggest that clozapine, but not haloperidol, may be effective at reducing alcohol abuse or non-dependent drinking and the P rat, used within an alcohol initiation paradigm, and may differentiate the effects of clozapine and haloperidol on alcohol drinking.
DOI: 10.1016/j.tins.2011.11.005
发表时间: 2012-01
影响因子: 15.9
作者:
Der-Avakian A;Markou A
通讯作者: Markou A
DOI: 10.3109/10673229909017206
发表时间: 1999-03-01
影响因子: 3.8
作者:
Green, AI;Zimmet, SV;Schildkraut, JJ
通讯作者: Schildkraut, JJ
DOI: 10.1016/0091-3057(77)90010-7
发表时间: 1977-01-01
影响因子: 3.6
作者:
MCMILLAN, DE;ELLIS, FW;PICK, JR
通讯作者: PICK, JR
DOI: 10.1016/j.neuropharm.2011.05.007
发表时间: 2011-09-01
期刊: NEUROPHARMACOLOGY
影响因子: 4.7
作者:
Chau, David T.;Ahmed, Jayme;Green, Alan I.
通讯作者: Green, Alan I.
DOI: 10.1093/schbul/sbs077
发表时间: 2013-05-01
影响因子: 6.6
作者:
Bedard, Anne-Marie;Maheux, Jerome;Samaha, Anne-Noel
通讯作者: Samaha, Anne-Noel